CAGR: 6.10%Current Market Size: USD 11.5 BillionFastest Growing Region: APAC
Largest Market: North AmericaProjection Time: 2022-2029Base Year: 2021
The Global Oral Anesthesia Delivery System market is expected to grow from USD 11.5 billion in 2021 to USD 18.4 billion by 2029, at a CAGR of 6.10% during the Projection period 2022-2029. The growth of this market is mainly driven owing to the growing use of anesthesia by end-users.
Anesthesia is a class of drugs that numbs the tissues of the mouth by blocking the nerves that perceive or transmit pain. It is used to prevent pain in a particular location of the mouth during treatment. Before administering a local anesthetic, your dentist may first numb the area with a topical anesthetic. Usual Symptoms Every kind of oral surgery can be performed under general anesthesia. Depending on their level of fear, a patient may decide to undergo basic procedures under a general anesthetic. Most people will select general anesthesia when having their wisdom teeth removed or a dental implant installed. Most local anesthetics cause numbness in the lips, tongue, and tooth of the patient for two to three hours following injection. The numb sensation will gradually disappear as the blood flow removes the anesthetic from the injection site to be metabolized or broken down. Local anesthesia, IV sedation, and general anesthesia are the three major forms of anesthesia frequently used in oral surgery.
Sample Request: - Global Oral Anesthesia Delivery System Market
Market Dynamics:
Drivers:
The market for oral anesthesia delivery systems has seen new technologies that offer improved solutions for oral anesthesia requirements. The market for dental anesthetic delivery systems may be significantly impacted by technological advancements that enable efficient dental operations. For instance, Carson City Pediatric Dentistry's innovative laser technology enables an anesthesia-free operation that significantly advances dentistry. The revolution in painless dental operations may present new opportunities for market participants in dental anesthesia delivery systems. In addition, developing WAND technology, a computer-assisted anesthesia system that enables painless anesthesia delivery, could open up significant market opportunities for dental anesthesia delivery systems. This is because the technology may one day replace dental anesthesia delivery systems. The market for manufacturers is anticipated to see growth prospects due to the demand for needleless oral anesthetic delivery methods. For instance, Biodent's Numbee Needleless dental anesthetic delivery devices make it easier to provide anesthetic while minimizing the need for injection methods and needles.
Restraints:
Depending on the anesthetic used, oral anesthesia can have certain side effects. When compared to local anesthetic or sedation, general anesthesia carries additional hazards. Additionally, other factors affect how people react. Slurred speech, dizziness, fatigue, numbness, lockjaw (trismus) brought on by trauma from surgery; the jaw opening is temporarily reduced, nausea or vomiting, headache, sweating or shivering, hallucinations, delirium, or confusion, are some of the side effects with sedatives and general anesthesia medications that have been reported. Adding vasoconstrictors to anesthetics, such as epinephrine, can potentially result in heart and blood pressure issues. The market is projected to suffer due to all these side effects during the Projection period.
Opportunities:
Analgesics, which reduce pain without impairing sensation, are fundamentally distinct from anesthetics. Only local anesthetic is used in dental anesthesia. In nonsurgical periodontal treatment (NSPT) procedures, dental anesthesia is employed. Nonsurgical periodontal therapy (NSPT) operations are generic procedures that, depending on the procedure, may necessitate a short or long period of anesthesia. The most used form of anesthetic is lidocaine. Its half-life in the body lasts between 1.5 and 2 hours. The tools used in local anesthesia include retractors, mouthpieces, syringes, and anesthetic capsules. Capsules are available in 1.7 and 1.8cc sizes, both blister- and canister-packaged. It includes local anesthetic and epinephrine preservatives.
Challenges
Some instances and circumstances where a physician or dentist will forgo using an anesthetic. It is not advisable for pregnant women, children with special needs, or other people to use an anesthetic. The Food and Drug Administration (FDA) has issued a warning concerning numbing medications frequently used to treat teething pain. Underage users of these products should avoid them. Use of these medications should only be done after consulting a healthcare provider. Special needs children and adults may experience additional medical issues that raise the dangers associated with anesthesia. For instance, according to a study trusted Source, general anesthesia-related adverse responses to the airways were most common in cerebral palsy children. This will limit the market growth.
Segmentation Analysis:
The global oral anesthesia delivery system market has been segmented based on End-Users and regions.
By End-User
The End-User segment is hospitals and clinics. The hospital segment led the largest share of the oral anesthesia delivery system market with a market share of around 55.3% in 2021. The need for oral anesthetic delivery systems is fueled by the availability of cutting-edge technology solutions that can serve a bigger population while providing the highest level of patient comfort.
Global Oral Anesthesia Delivery System Market- By Regional Analysis:
The regions analyzed for the oral anesthesia delivery system market include North America, Europe, South America, Asia Pacific, the Middle East, and Africa. The North American region dominated the oral anesthesia delivery system market and held a 39.6% share of the market revenue in 2021.
Global Oral Anesthesia Delivery System Market- Country Analysis:
Germany's oral anesthesia delivery system market size was valued at USD 0.7 billion in 2021 and is expected to reach USD 1.09 billion by 2029, at a CAGR of 5.8% from 2022 to 2029. Due to the expanding commercial insurance and Medicaid coverage in Germany, there is a rising demand for oral anesthetic delivery systems. A private health insurance policy reduces out-of-pocket costs by over 80%. This stimulates the nation's market.
China’s oral anesthesia delivery system’s market size was valued at USD 1.4 billion in 2021 and is expected to reach USD 2.3 billion by 2029, at a CAGR of 6.8% from 2022 to 2029. Growing Number of Dental Root Canal and Tooth Restoration Cases, with Growing Rate of Operations The country's rising tooth infections and diseases, which strengthen the oral anesthetic delivery system, are blamed for the sharp increase in tooth restoration.
India's oral anesthesia delivery system market size was valued at USD 1.1 billion in 2021 and is expected to reach USD 1.8 billion by 2029, at a CAGR of 6.5% from 2022 to 2029. As the nation's senior population rises, it is anticipated that demand for oral anesthetic administration methods will rise dramatically. Additionally, the growth of the dental and oral care industries presents a potential boost for oral anesthetics due to patient demand for painless procedures.
Key Industry Players Analysis:
To increase their market position in the global oral anesthesia delivery system business, top companies focus on tactics such as adopting new technology, mergers & acquisitions, product developments, collaborations, partnerships, joint ventures, etc.
Latest Development:
Report Metrics
Report Attribute |
Details |
Study Period |
2021-2029 |
Base year |
2021 |
CAGR (%) |
6.10% |
Market Size |
11.5 billion 2021 |
Projection period |
2022-2029 |
Projection unit |
Value (USD) |
Segments covered |
By End-User, Region |
Report Scope |
Revenue Projection, competitive landscape, company ranking, growth factors, and trends |
Companies covered |
Milestone Scientific, 3M, Dentsply Sirona, BD, Henke Sass Wolf, Carl Martin GmbH, Video Dental Concepts, Hager Werken, 4tek Srl, and Sedana Medical among others. |
By End User |
|
Regional scope |
|
Scope of the Report
Global Oral Anesthesia Delivery System Market by End-User:
Global Oral Anesthesia Delivery System Market by Region:
Global Oral Anesthesia Delivery System market size was USD 11.5 billion.
North American region dominated the oral anesthesia delivery system market and held a 39.6% share of the market revenue in 2021.
Global oral anesthesia delivery system market is expected to reach USD 18.4 billion by 2029, at a CAGR of 6.10% from 2022 to 2029.
Leading market players active in the global oral anesthesia delivery system market are Milestone Scientific, 3M, Dentsply Sirona, BD, Henke Sass Wolf, Carl Martin GmbH, Video Dental Concepts, Hager Werken, 4tek Srl, and Sedana Medical among others.
Rapid increase in dental disorders is primarily driving the growth of the oral anesthesia delivery system market.
Political Factors- Most nations maintain frameworks containing rules about certification requirements, safety standards, etc. They also identify the substances that are prohibited and may be harmful to your health. A pharmaceutical company's business can suffer significantly if it disregards those rules. The majority of governments strive to keep drug prices under control so that consumers can afford them. The expansion of pharmaceutical businesses might suffer as a result. Several governments provide financial assistance to pharmaceutical firms to maintain the cost of essential medications affordable for the general public. It aids businesses in surviving in a cutthroat marketplace.
Economical Factors- The average household income is rising with the improvement in the economies of the various nations. They could get access to some necessary medications. They could feel compelled to purchase more expensive medications previously out of reach for many people. The manufacture of more advantageous and potentially useful drugs is the consequence of the researchers' ongoing work on medication modification. As more people purchase those medications, the pharmaceutical sector is likewise booming. Families are spending more on healthcare on average. A family is more likely to incur large healthcare costs if there are elderly members. It also covers the price of prescription drugs. Even after adhering to government pricing limits, it enables pharmaceutical companies to make a higher profit.
Social Factor- People today live extremely quick yet unchanging lives. As a result, obesity is becoming increasingly prevalent. Resulting in diseases like diabetes, thyroid, and hypertension. To manage this, the patients need constant medicine. As a result, pharmaceutical businesses' sales are also rising. The elderly population is increasing at the same time that the healthcare system nationwide has improved. As a result, they require more medications than children of younger age do. It increases demand, which causes pharmaceutical businesses to expand. Many people are focusing on leading healthy lives while engaging in exercise and eating well. It might lead to a future decline in the demand for medications.
Technological Factors- Technology plays a significant role in the pharmaceutical sector. Drugs with high quality and low production costs are now being produced thanks to research and biotechnology advances. More people will be able to receive medications that they previously wouldn't have been able to buy. The medications need to be stored properly. The advancement of technology has made it simpler to store medicines and transfer them without risking damage from unfavorable circumstances. Pharmaceutical companies now can advertise to more businesses thanks to technology. The companies' reach has expanded because they can now bring medicine to the door. Additionally, it may boost pharmaceutical companies' earnings.
Environmental Factors- Many nations are developing measures to lessen the impact on the environment because the production of pharmaceuticals has a significant carbon footprint. Because complying with these rules could be expensive for new businesses, they might not succeed in starting up. Different biotechnology contaminants are produced as a result of medication synthesis. They could endanger the health of humans. To keep people safe, the business must manage this trash. Pharmaceutical firms may adopt some corporate environmental responsibility, much as other businesses. They can improve their reputation by making financial donations or running campaigns for certain environmental concerns.
Legal Factors- The government always employs regulations to control the fraud-related production of the batch of pharmaceuticals and expiration dates because pharmaceutical products are among the most important ones. A firm may be subject to legal action if it disregards the established rules. The database is what pharmaceutical corporations rely on the most. Customers may lose trust in them if cyber threats victimize them. It may also have an impact on their business. Pharmaceutical businesses should adhere to severe legal requirements when creating the foundation for their operations and research. They guarantee the product's safety. They benefit from avoiding legal problems. Consequently, they were able to avoid the steep costs of the procedures.
List of Table
List of Figures